Table 1 Baseline clinical and demographics features of the study patients
From: Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study
Items | GD | HT | Controls |
|---|---|---|---|
Number | 634 | 383 | 856 |
Gender | |||
Male | 188 (29.65%) | 55 (14.36%) | 357 (41.71%) |
Female | 446 (70.35%) | 328 (85.64%) | 499 (58.29%) |
Age (years) | 41.57 ± 14.47 | 41.59 ± 14.43 | 39.30 ± 9.71 |
Goiter | |||
No goiter | 127 (20.03%) | 155 (40.47%) | – |
Degree I | 171 (26.97%) | 92 (24.02%) | – |
Degree II | 293 (46.21%) | 128 (33.42%) | – |
Degree III | 43 (6.79%) | 8 (2.09%) | – |
Family history | |||
(+) | 135 (21.29%) | 61 (15.93%) | – |
(−) | 499 (78.71%) | 322 (84.07%) | – |
Ophthalmopathy | |||
(+) | 100 (15.77%) | 3 (0.78%) | – |
(−) | 534 (84.23%) | 380 (99.22%) | – |